Passage BIO, Inc. — Form D

Passage BIO, Inc. of PHILADELPHIA, PA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2019-09-06. The offering totals $110.0M, of which $110.0M was reported sold. Industry: Other Health Care.

Offering

Filed: 2019-09-06
Form: D
Accession: 0001787297-19-000001
Industry: Other Health Care
Exemptions: 06b, 3C, 3C.1
Total offering: $110.0M
Amount sold: $110.0M
Remaining: $26
Investors: 15
Date of first sale: 2019-08-21
Security types: equity, fund interests
Revenue range: Decline to Disclose
SEC file number: 021-348117

Issuer

Name: Passage BIO, Inc.
CIK: 0001787297
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2017
Address: TWO COMMERCE SQUARE, PHILADELPHIA, PA, 19103
Phone: 2678660312

Officers, directors & promoters (9)

Name	Role	Location
CARL GORDON	Director	SAN DIEGO, CA
Patrick Heron	Director	Philadelphia, PA
Saqib Islam	Director	Stamford, CT
Stephen Squinto	Director	Stamford, CT
Thomas Street Address 1 Woiwode	Director	Philadelphia, PA
Tadataka Yamada	Director	Philadelphia, PA
Stephen Squinto	Executive Officer	Stamford, CT
Tadataka Yamada	Executive Officer	Philadelphia, PA
Tadataka Yamada	Promoter	Philadelphia, PA

More